Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELY

Author:

,Curtis Helen JORCID,Inglesby Peter,Morton Caroline EORCID,MacKenna BrianORCID,Walker Alex JORCID,Morley JessicaORCID,Mehrkar AmirORCID,Bacon SebORCID,Hickman George,Bates ChrisORCID,Croker RichardORCID,Evans David,Ward Tom,Cockburn JonathanORCID,Davy Simon,Bhaskaran KrishnanORCID,Schultze AnnaORCID,Rentsch Christopher TORCID,Williamson Elizabeth,Hulme WilliamORCID,Green AmeliaORCID,Rowan Anna,Fisher Louis,McDonald Helen IORCID,Tomlinson LaurieORCID,Mathur RohiniORCID,Drysdale HenryORCID,Eggo Rosalind MORCID,Wing KevinORCID,Wong Angel YSORCID,Forbes HarrietORCID,Parry John,Hester Frank,Harper Sam,O’Hanlon ShaunORCID,Eavis AlexORCID,Jarvis RichardORCID,Avramov DimaORCID,Griffiths PaulORCID,Fowles AaronORCID,Parkes Nasreen,Douglas Ian JORCID,Evans Stephen JWORCID,Smeeth LiamORCID,Goldacre BenORCID

Abstract

AbstractBackgroundOn December 8th 2020, NHS England administered the first COVID-19 vaccination as part of an ambitious vaccination programme during a global health emergency.AimsTo describe trends and variation in vaccine coverage by key clinical and demographic groups; to create a framework for near-real-time monitoring of vaccine coverage in key subgroups.MethodsWorking on behalf of NHS England we analysed 57.9 million patient records in situ and in near-real-time within the infrastructure of the Electronic Health Record (EHR) software vendors EMIS and TPP using OpenSAFELY. We describe vaccine coverage and time trends across a range of demographic and fine-grained clinical subgroups in eight Joint Committee on Vaccination and Immunisation (JCVI) priority cohorts.Results20,852,692 patients (36%) received a COVID-19 vaccine between December 8th 2020 and March 17th 2021. Of patients aged ≥80 not in a care home (JCVI group 2) 94.7% received a vaccine, but with substantial variation by ethnicity (White 96.2% vaccinated, Black 68.3%) and deprivation (least deprived 96.6%, most deprived 90.7%). Overall, patients with pre-existing medical conditions were equally or more likely to be vaccinated with two exceptions: severe mental illness (89.5% vaccinated) and learning disability (91.4%). 275,205 vaccine recipients were identified as care home residents (priority group 1; 91.2% coverage). 1,257,914 (6.0%) recipients have had a second dose. Detailed characteristics of recipients in all cohorts are reported.ConclusionsThe NHS in England has rapidly delivered mass vaccination. We were able to deploy a data monitoring framework using publicly auditable methods and a secure, in-situ processing model, using linked but pseudonymised patient-level NHS data on 57.9 million patients with very short delays from vaccine administration to completed analysis. Targeted activity may be needed to address lower vaccination coverage observed among certain key groups: ethnic minorities, those living in deprived areas, and people with severe mental illness or learning disabilities.

Publisher

Cold Spring Harbor Laboratory

Reference43 articles.

1. Ten threats to global health in 2019. WHO. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed 19 Jan 2021).

2. Draft landscape of COVID-19 candidate vaccines. WHO. 2021.https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed 19 Jan 2021).

3. Department of Health and Social Care. Oxford University/AstraZeneca vaccine authorised by UK medicines regulator. GOV.UK. 2020.https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator (accessed 19 Jan 2021).

4. Medicines and Healthcare products Regulatory Agency. Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator. GOV.UK. 2021.https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator (accessed 20 Jan 2021).

5. Public Health England. The Green Book, chapter 14a - COVID-19. 2020.https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a (accessed 19 Jan 2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3